Rgenix is a privately-held clinical-stage biopharmaceutical company developing first-in-class drugs that target key pathways in cancer progression.

310 E 67th St, Suite 1-12‎, New York, NY 10065
(646) 856-9261
info@inspirna.com

News

21st Annual Needham Virtual Healthcare Conference

Oppenheimer 32nd Annual Healthcare Conference

Piper Sandler 33rd Annual Virtual Healthcare Conference